These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 6874818)
1. Analysis of N-n-propylnorapomorphine in plasma and tissue by capillary gas chromatography--electron-capture detection. Maksoud HM; Kuttab SH; Neumeyer JL; Vouros P J Chromatogr; 1983 May; 274():149-59. PubMed ID: 6874818 [TBL] [Abstract][Full Text] [Related]
2. Determination of N-n-propylnorapomorphine in serum and brain tissue by gas chromatography-negative ion chemical ionization mass spectrometry. Trainor TM; Vouros P; Lampen P; Neumeyer JL; Baldessarini RJ; Kula NS J Chromatogr; 1988 Dec; 457():257-66. PubMed ID: 3243885 [TBL] [Abstract][Full Text] [Related]
3. Tissue levels of N-n-propylnorapomorphine after treatment with (-)10,11-methylenedioxy-N-n-propylnoraporphine, an orally long-acting prodrug active at central dopamine receptors. Sperk G; Campbell A; Baldessarini RJ; Stoll A; Neumeyer JL Neuropharmacology; 1982 Dec; 21(12):1311-6. PubMed ID: 6891445 [TBL] [Abstract][Full Text] [Related]
4. High-performance liquid chromatographic separation and electrochemical or spectrophotometric determination of R(-)N-n-propylnorapomorphine and R(-)10,11-methylenedioxy-N-n-propylnoraporphine in primate plasma. Lampen P; Neumeyer JL; Baldessarini RJ J Chromatogr; 1988 Apr; 426(2):283-94. PubMed ID: 3392141 [TBL] [Abstract][Full Text] [Related]
5. S(+)methylenedioxy-N-n-propylnoraporphine: an orally active inhibitor of dopamine selective for rat limbic system. Campbell A; Baldessarini RJ; Kula NS; Ram VJ; Neumeyer JL Brain Res; 1987 Feb; 403(2):393-7. PubMed ID: 3828830 [TBL] [Abstract][Full Text] [Related]
6. Behavioral effects of (-)10,11-methylenedioxy-N-n-propylnoraporphine, an orally effective long-acting agent active at central dopamine receptors, and analogous aporphines. Campbell A; Baldessarini RJ; Ram VJ; Neumeyer JL Neuropharmacology; 1982 Oct; 21(10):953-61. PubMed ID: 6890636 [TBL] [Abstract][Full Text] [Related]
7. Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptors. Köhler C; Fuxe K; Ross SB Eur J Pharmacol; 1981 Jul; 72(4):397-402. PubMed ID: 7274333 [TBL] [Abstract][Full Text] [Related]
8. In vivo binding of N-n-propylnorapomorphine in the rat brain: regional localization, quantification in striatum and lack of correlation with dopamine metabolism. van der Werf JF; Sebens JB; Vaalburg W; Korf J Eur J Pharmacol; 1983 Feb; 87(2-3):259-70. PubMed ID: 6404643 [TBL] [Abstract][Full Text] [Related]
9. Autoradiographic localization and quantification of dopamine D2 receptors in normal human brain with [3H]N-n-propylnorapomorphine. Camus A; Javoy-Agid F; Dubois A; Scatton B Brain Res; 1986 Jun; 375(1):135-49. PubMed ID: 3719352 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and dopamine receptor affinities of enantiomers of 2-substituted apomorphines and their N-n-propyl analogues. Gao YG; Baldessarini RJ; Kula NS; Neumeyer JL J Med Chem; 1990 Jun; 33(6):1800-5. PubMed ID: 1971309 [TBL] [Abstract][Full Text] [Related]
11. Autoradiographic localization of dopamine receptors in the spinal cord of the rat using [3H]-N-propylnorapomorphine. Scatton B; Dubois A; Cudennec A J Neural Transm; 1984; 59(3):251-6. PubMed ID: 6736950 [TBL] [Abstract][Full Text] [Related]
12. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines. Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the dopaminergic effects of apomorphine and (-)-N-n-propylnorapomorphine. Menon MK; Clark WG; Neumeyer JL Eur J Pharmacol; 1978 Nov; 52(1):1-9. PubMed ID: 569056 [TBL] [Abstract][Full Text] [Related]
14. Gas chromatographic determination of apomorphine in plasma. Baaske DM; Keiser JE; Smith RV J Chromatogr; 1977 Oct; 140(1):57-64. PubMed ID: 893632 [TBL] [Abstract][Full Text] [Related]
15. Radiosynthesis and ex vivo evaluation of (R)-(-)-2-chloro-N-[1-11C-propyl]n-propylnorapomorphine. Palner M; McCormick P; Gillings N; Begtrup M; Wilson AA; Knudsen GM Nucl Med Biol; 2010 Jan; 37(1):35-40. PubMed ID: 20122666 [TBL] [Abstract][Full Text] [Related]
16. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions. Baldessarini RJ; Marsh ER; Kula NS; Zong RS; Gao YG; Neumeyer JL Biochem Pharmacol; 1990 Aug; 40(3):417-23. PubMed ID: 2383279 [TBL] [Abstract][Full Text] [Related]
17. Differences in dopamine receptor reserve for N-n-propylnorapomorphine enantiomers: single unit recording studies after partial inactivation of receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline. Cox RF; Waszczak BL Mol Pharmacol; 1989 Jan; 35(1):125-31. PubMed ID: 2563304 [TBL] [Abstract][Full Text] [Related]
18. Aporphines 65: chemical, microbial synthesis and characterization by gas chromatography/mass spectrometry of (R)-(-)-10-hydroxy 11-methoxy-N-n-propylnoraporphine, a potential metabolite of N-n-propylnorapomorphine. Neumeyer JL; Abdel-Maksoud HM; Trainor TM; Vouros P; Davis PJ Biomed Environ Mass Spectrom; 1986 May; 13(5):223-9. PubMed ID: 2941089 [TBL] [Abstract][Full Text] [Related]
20. Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration. Hall MD; Jenner P; Marsden CD Biochem Pharmacol; 1983 Oct; 32(19):2973-7. PubMed ID: 6626267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]